Clear Search

Showing 1 result for “Zufferey P”.

June 2020

Efficacité comparative des agents anti-facteur de nécrose tumorale, agents biologiques avec un mode d'action alternatif et du tofacitinib dans une cohorte observationnelle de patients atteints de polyarthrite rhumatoïde en Suisse

RMD Open 2020;6:e001174 doi:10.1136/rmdopen-2020-001174

This nested cohort study found that, in Switzerland, there was a generally limited overall drug maintenance for b/tsDMARD options in RA. Using data from SCQM-RA – a prospective longitudinal registry, overall maintenance (drug survival) was calculated for TNFi, bDMARD-OMA or JAKi in patients with RA.After adjusting for potential confounding factors, there was a higher hazard of drug discontinuation with TNFi compared with tofacitinib; no significant difference was observed between non-TNF bDMARDs...